Tycoon Group Holdings Ltd
Tycoon Group Holdings Ltd has a market capitalization of $241.38 million and a price-to-earnings ratio of 15.4, indicating a moderate valuation relative to earnings. The company's price-to-book ratio of 0.45 suggests that the market values the company at a discount to its book value. The enterprise value to EBITDA ratio of 13.76 and enterprise value to revenue ratio of 0.55 indicate that the company is valued at a relatively low multiple of its earnings and revenue. The company's profitability metrics show a return on equity of 2.92% and a return on assets of 1.34%, both of which are below the industry median for pharmaceuticals. The gross profit margin of 24.7% and operating margin of 4.0% suggest that the company is generating modest profitability, with a significant portion of revenue consumed by operating expenses. Tycoon Group Holdings Ltd's revenue is distributed across three segments: Distribution, Retail Stores, and Online Stores. The company's geographic exposure is not explicitly detailed in the input data, but the presence of online stores suggests a potential for broader geographic reach. The company's revenue concentration across segments is not disclosed, but the presence of three distinct segments indicates a diversified revenue model. The company's growth trajectory is not explicitly detailed in the input data, but the current liquidity position and capital structure suggest a stable but not rapidly growing business. The company's free cash flow of $39.57 million and operating cash flow of $96.95 million indicate a positive cash flow position, which supports the company's liquidity and operational flexibility. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company's cash reserves are insufficient to cover its long-term debt obligations. The debt-to-equity ratio of 0.8 indicates a moderate level of leverage, which is below the industry median for pharmaceuticals. Recent events and filings for Tycoon Group Holdings Ltd are not explicitly detailed in the input data. However, the company's financial snapshot and valuation metrics suggest a stable but not rapidly growing business with a moderate level of leverage and a positive cash flow position.
Business. Tycoon Group Holdings Ltd is an investment holding company engaged in the provision of proprietary Chinese medicine (PCM) and health supplement products, operating through distribution, retail stores, and online stores segments.
Classification. Tycoon Group Holdings Ltd is classified under the Healthcare economic sector, specifically in the Pharmaceuticals & Medical Research business sector, with a classification confidence of 0.92.
- Tycoon Group Holdings Ltd has a moderate valuation with a price-to-earnings ratio of 15.4 and a price-to-book ratio of 0.45.
- The company's profitability metrics, including a return on equity of 2.92% and a return on assets of 1.34%, are below the industry median for pharmaceuticals.
- The company's revenue is distributed across three segments: Distribution, Retail Stores, and Online Stores, indicating a diversified revenue model.
- The company's free cash flow of $39.57 million and operating cash flow of $96.95 million support its liquidity and operational flexibility.
- The company's risk assessment indicates a medium liquidity risk and a low dilution risk, with a debt-to-equity ratio of 0.8.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.